Mechanical characterization and design of flexible silicon microstructures von Lisby, T., Nikles, S.A., Najafi, K., Hansen, O., Bouwstra, S., Branebjerg, J.A.

Volltext

A UNITARY FLEXIBLE AND MECHANICALLY AND CHEMICALLY ROBUST MICROSYSTEM AND A METHOD FOR PRODUCING SAME von LISBY, TORBEN, BRANEBJERG, JENS, A

Volltext bestellen

A UNITARY FLEXIBLE AND MECHANICALLY AND CHEMICALLY ROBUST MICROSYSTEM AND A METHOD FOR PRODUCING SAME von LISBY, TORBEN, BRANEBJERG, JENS, A

Volltext bestellen

A unitary flexible microsystem and a method for producing same von BRANEBJERG, JENS A, LISBY, TORBEN

Volltext bestellen

Daratumumab, Lenalidomide, and Dexamethasone for Multiple Myeloma von Dimopoulos, Meletios A, Oriol, Albert, Nahi, Hareth, San-Miguel, Jesus, Bahlis, Nizar J, Usmani, Saad Z, Rabin, Neil, Orlowski, Robert Z, Komarnicki, Mieczyslaw, Suzuki, Kenshi, Plesner, Torben, Yoon, Sung-Soo, Ben Yehuda, Dina, Richardson, Paul G, Goldschmidt, Hartmut, Reece, Donna, Lisby, Steen, Khokhar, Nushmia Z, O’Rourke, Lisa, Chiu, Christopher, Qin, Xiang, Guckert, Mary, Ahmadi, Tahamtan, Moreau, Philippe

Volltext

Targeting CD38 with Daratumumab Monotherapy in Multiple Myeloma von Lokhorst, Henk M, Plesner, Torben, Laubach, Jacob P, Nahi, Hareth, Gimsing, Peter, Hansson, Markus, Minnema, Monique C, Lassen, Ulrik, Krejcik, Jakub, Palumbo, Antonio, van de Donk, Niels W.C.J, Ahmadi, Tahamtan, Khan, Imran, Uhlar, Clarissa M, Wang, Jianping, Sasser, A. Kate, Losic, Nedjad, Lisby, Steen, Basse, Linda, Brun, Nikolai, Richardson, Paul G

Volltext

Phase 1/2 study of daratumumab, lenalidomide, and dexamethasone for relapsed multiple myeloma von Plesner, Torben, Arkenau, Hendrik-Tobias, Gimsing, Peter, Krejcik, Jakub, Lemech, Charlotte, Minnema, Monique C., Lassen, Ulrik, Laubach, Jacob P., Palumbo, Antonio, Lisby, Steen, Basse, Linda, Wang, Jianping, Sasser, A. Kate, Guckert, Mary E., de Boer, Carla, Khokhar, Nushmia Z., Yeh, Howard, Clemens, Pamela L., Ahmadi, Tahamtan, Lokhorst, Henk M., Richardson, Paul G.

Volltext

Daratumumab, Lenalidomide, and Dexamethasone for Multiple Myeloma von Dimopoulos, Meletios A., Oriol, Albert, Nahi, Hareth, San-Miguel, Jesus, Bahlis, Nizar J., Usmani, Saad Z., Rabin, Neil, Orlowski, Robert Z., Komarnicki, Mieczyslaw, Suzuki, Kenshi, Plesner, Torben, Yoon, Sung-Soo, Ben Yehuda, Dina, Richardson, Paul G., Goldschmidt, Hartmut, Reece, Donna, Lisby, Steen, Khokhar, Nushmia Z., O’Rourke, Lisa, Chiu, Christopher, Qin, Xiang, Guckert, Mary, Ahmadi, Tahamtan, Moreau, Philippe

Volltext

Epidermal Overexpression of Interleukin-19 and -20 mRNA in Psoriatic Skin Disappears After Short-Term Treatment with Cyclosporine A or Calcipotriol von Steiniche, Torben, Kragballe, Knud, Rømer, John, Hasselager, Erik, Nørby, Peder Lisby, Thorn Clausen, Jes

Volltext

Daratumumab, a CD38 Monoclonal Antibody in Patients with Multiple Myeloma - Data From a Dose-Escalation Phase I/II Study von Plesner, Torben, Lokhorst, Henk, Gimsing, Peter, Nahi, Hareth, Lisby, Steen, Richardson, Paul G.

Volltext

Daratumumab, a CD38 mab, for the treatment of relapsed/refractory multiple myeloma patients: Preliminary efficacy data from a multicenter phase I/II study von Plesner, Torben, Lokhorst, Henk M, Gimsing, Peter, Nahi, Hareth, Lisby, Steen, Richardson, Paul Gerard Guy

Volltext

A Phase I/II, Dose-Escalation Study of Daratumumab, A CD38 Mab in Patients with Multiple Myeloma – Preliminary Safety Data von Gimsing, Peter, Plesner, Torben, Nahi, Hareth, Lokhorst, Henk, Valentin, Marie-Louise, Lisby, Steen, Richardson, Paul G.

Volltext

Daratumumab in Combination with Lenalidomide and Dexamethasone in Patients with Relapsed or Relapsed and Refractory Multiple Myeloma: Updated Results of a Phase 1/2 Study (GEN503) von Plesner, Torben, Arkenau, Hendrik-Tobias, Gimsing, Peter, Krejcik, Jakub, Lemech, Charlotte, Minnema, Monique C., Lassen, Ulrik, Laubach, Jacob P., Palumbo, Antonio, Lisby, Steen, Basse, Linda, Wang, Jianping, Sasser, A Kate, Guckert, Mary E, Yeh, Howard, Ahmadi, Tahamtan, Lokhorst, Henk M., Richardson, Paul G.

Volltext

Phase I/II dose-escalation study of daratumumab in patients with relapsed or refractory multiple myeloma von Lokhorst, Henk M, Plesner, Torben, Gimsing, Peter, Nahi, Hareth, Minnema, Monique, Lassen, Ulrik Niels, Krejcik, Jakub, Laubach, Jacob, Lisby, Steen, Basse, Linda, Richardson, Paul Gerard Guy

Volltext

Safety and efficacy of daratumumab with lenalidomide and dexamethasone in relapsed or relapsed, refractory multiple myeloma von Plesner, Torben, Arkenau, Hendrik-Tobias, Lokhorst, Henk M., Gimsing, Peter, Krejcik, Jakub, Lemech, Charlotte Rose, Minnema, Monique, Lassen, Ulrik Niels, Ahmadi, Tahamtan, Yeh, Howard, Guckert, Mary, Brun, Nikolai C., Lisby, Steen, Basse, Linda, Palumbo, Antonio, Richardson, Paul G.

Volltext

Safety and Efficacy of Daratumumab with Lenalidomide and Dexamethasone in Relapsed or Relapsed, Refractory Multiple Myeloma von Plesner, Torben, Arkenau, Hendrik-Tobias, Lokhorst, Henk M., Gimsing, Peter, Krejcik, Jakub, Lemech, Charlotte, Minnema, Monique C., Lassen, Ulrik, Laubach, Jacob P., Ahmadi, Tahamtan, Yeh, Howard, Guckert, Mary E, Feng, Huaibao, Brun, Nikolai Constantin, Lisby, Steen, Basse, Linda, Palumbo, Antonio, Richardson, Paul G.

Volltext

Dose-dependent efficacy of daratumumab (DARA) as monotherapy in patients with relapsed or refractory multiple myeloma (RR MM) von Lokhorst, Henk M., Laubach, Jacob, Nahi, Hareth, Plesner, Torben, Gimsing, Peter, Hansson, Markus, Minnema, Monique, Lassen, Ulrik Niels, Krejcik, Jakub, Ahmadi, Tahamtan, Lisby, Steen, Basse, Linda, Brun, Nikolai C., Richardson, Paul G.

Volltext

SCFV AND ANTIBODIES WITH REDUCED MULTIMERISATION von LISBY, Steen, LIEBENBERG, Nico, LUND-HANSEN, Torben, MORTENSEN, Matias Munck

Volltext bestellen

SCFV AND ANTIBODIES WITH REDUCED MULTIMERISATION von LISBY, Steen, LIEBENBERG, Nico, LUND-HANSEN, Torben, MORTENSEN, Matias Munck

Volltext bestellen

SCFV AND ANTIBODIES WITH REDUCED MULTIMERISATION von MORTENSEN, MATIAS MUNCK, LUND-HANSEN, TORBEN, LISBY, STEEN, LIEBENBERG, NICO

Volltext bestellen